Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab with Chemoradiation for Locally Advanced Pancreatic Cancer
NCT00601627Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2009
- Primary completion
- Jul 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in pancreatic cancer (PC), sponsored by Cancer and Leukemia Group B. Started Jun 2009; status: completed.
02
Drugs
panitumumab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00601627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601627.